drugset
drugset / Trial / NCT04858659

A Phase 3 Study to Assess the Efficacy and Safety of PK101 in Patients With Knee Osteoarthritis

NCT04858659 ↗

Phase 3 Unknown 354 enrolled PMG Pharm Co., Ltd
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to compare the efficacy and the safety of PK101 in patients with knee osteoarthritis.

Timeline

Start
2021-05-20
Primary completion
2022-03-15
Completion
2022-03-15

Drugs

EvaluationDrugModalityDoseRoute
Subject PK101 Unknown — —
Comparator PK101-002 Unknown — —

Indications

osteoarthritis, knee